SCHEMBL18734960

SCHEMBL18734960

CCN(CC)C(=O)C(CSC(=O)C(=O)CC(=O)OC(C)C)NC(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18734969 0.91 — —
SCHEMBL18734954 0.90 — —
SCHEMBL18734967 0.88 — —
SCHEMBL18735188 0.88 ALOX15 (0.32) —
SCHEMBL18735337 0.82 CYP1A2 (0.36) —
SCHEMBL18734971 0.81 — —
SCHEMBL18734936 0.81 ALOX15 (0.31) —
SCHEMBL18734956 0.79 MGAM (0.32) —
SCHEMBL18735171 0.78 ALOX15 (0.33) —
SCHEMBL18735170 0.77 CNR2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback